Showing 1 - 8 results of 8 for search 'Adele P Williams', query time: 0.03s Refine Results
  1. 1
    A pediatric case of xanthogranulomatous pyelonephritis in the setting of Covid-19 and multi-system inflammatory syndrome (MIS-C)

    A pediatric case of xanthogranulomatous pyelonephritis in the setting of Covid-19 and multi-system inflammatory syndrome (MIS-C) by Janet R. Julson, MD Sibat Noor, Adele P. Williams, Jason Wicker, Elizabeth A. Beierle

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma

    Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma by Laura L. Stafman, Adele P. Williams, Evan F. Garner, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Kimberly Whelan, Elizabeth A. Beierle

    Published 2019-02-01
    Get full text
    Article
  3. 3
    Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth

    Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth by Adele P. Williams, Evan F. Garner, Alicia M. Waters, Laura L. Stafman, Jamie M. Aye, Hooper Markert, Jerry E. Stewart, Elizabeth A. Beierle

    Published 2019-01-01
    Get full text
    Article
  4. 4
    FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

    FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts by Evan F. Garner, Adele P. Williams, Laura L. Stafman, Jamie M. Aye, Elizabeth Mroczek-Musulman, Blake P. Moore, Jerry E. Stewart, Gregory K. Friedman, Elizabeth A. Beierle

    Published 2018-05-01
    Get full text
    Article
  5. 5
    PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma

    PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma by Raoud Marayati, Laura L. Stafman, Adele P. Williams, Laura V. Bownes, Colin H. Quinn, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Joshua C. Anderson, Christopher D. Willey, Elizabeth A. Beierle

    Published 2021-03-01
    Get full text
    Article
  6. 6
    EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.

    EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth. by Laura V Bownes, Adele P Williams, Raoud Marayati, Laura L Stafman, Hooper Markert, Colin H Quinn, Nikita Wadhwani, Jamie M Aye, Jerry E Stewart, Karina J Yoon, Elizabeth Mroczek-Musulman, Elizabeth A Beierle

    Published 2021-01-01
    Get full text
    Article
  7. 7
    UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts

    UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts by Adele P. Williams, Evan F. Garner, Laura L. Stafman, Jamie M. Aye, Colin H. Quinn, Raoud Marayati, Jerry E. Stewart, Venkatram R. Atigadda, Elizabeth Mroczek-Musulman, Blake P. Moore, Elizabeth A. Beierle, Gregory K. Friedman

    Published 2019-10-01
    Get full text
    Article
  8. 8
    Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines

    Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines by Laura V Bownes, Adele P Williams, Raoud Marayati, Colin H Quinn, Sara C Hutchins, Jerry E Stewart, Trung Vu, Juliet L Easlick, Elizabeth Mroczek-Musulman, David K Crossman, Joshua C Anderson, Christopher D Willey, Pran K Datta, Elizabeth A Beierle

    Published 2021-06-01
    Get full text
    Article

Search Tools: